Antithrombotic Treatment of Embolic Stroke of Undetermined Source RE-SPECT ESUS Elderly and Renally Impaired Subgroups

BACKGROUND AND PURPOSE—: The RE-SPECT ESUS trial (Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate Versus Acetylsalicylic Acid in Patients With Embolic Stroke of Undetermined Source) tested the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans-Christoph, Sacco, Ralph L., Easton, J. Donald, Granger, Christopher B., Bar, Michal, Bernstein, Richard A., Brainin, Michael, Brueckmann, Martina, Cronin, Lisa, Donnan, Geoffrey, Gdovinová, Zuzana, Grauer, Claudia, Kleine, Eva, Kleinig, Timothy J., Lyrer, Philippe, Martins, Sheila, Meyerhoff, Juliane, Milling, Truman, Pfeilschifter, Waltraud, Poli, Sven, Reif, Michal, Rose, David Z., Šaňák, Daniel, Schäbitz, Wolf-Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379165/
https://www.ncbi.nlm.nih.gov/pubmed/32404035
http://dx.doi.org/10.1161/STROKEAHA.119.028643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379165/
https://www.ncbi.nlm.nih.gov/pubmed/32404035
http://dx.doi.org/10.1161/STROKEAHA.119.028643

Ejemplares similares